SUPERNUS PHARMACEUTICALS, INC. Other Non-Current Assets
SUPERNUS PHARMACEUTICALS, INC. (SUPN) had Other Non-Current Assets of $55.02 million as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2026-08-03
- 2026-06-30: Other Assets, Noncurrent $55.02M.
- 2026-03-31: Other Assets, Noncurrent $56.45M.
- 2025-12-31: Other Assets, Noncurrent $63.80M.
- 2025-09-30: Other Assets, Noncurrent $62.43M.
| Period end | Other Assets, Noncurrent | Other Assets, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $55.02M 10-Q · filed 2026-08-03 | |
| 2026-03-31 | $56.45M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $63.80M 10-Q · filed 2026-08-03 | |
| 2025-09-30 | $62.43M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $27.96M 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $29.22M 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $31.53M 10-K · filed 2026-03-02 | |
| 2024-09-30 | $33.65M 10-Q · filed 2024-11-04 | |
| 2024-06-30 | $35.89M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $38.37M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $37.51M 10-K · filed 2025-02-25 | |
| 2023-09-30 | $38.82M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $38.49M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $40.18M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $39.81M 10-Q · filed 2023-11-08 | |
| 2022-09-30 | $41.29M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $47.34M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $48.99M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $49.23M 10-K · filed 2023-03-09 | |
| 2021-09-30 | $40.13M 10-Q · filed 2021-11-05 | |
| 2021-06-30 | $40.69M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $30.26M 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $43.25M 10-K · filed 2022-04-13 | |
| 2020-09-30 | $18.32M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $17.12M 10-Q · filed 2020-08-17 | |
| 2020-03-31 | $538.00K 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $21.89M 10-K · filed 2021-03-08 | $615.00K 10-K · filed 2020-02-28 |
| 2019-09-30 | $574.00K 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $581.00K 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $625.00K 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $380.00K 10-K · filed 2020-02-28 | |
| 2018-09-30 | $782.00K 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $752.00K 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $735.00K 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $389.00K 10-K · filed 2019-03-01 | |
| 2017-09-30 | $368.00K 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $349.00K 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $350.00K 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $331.00K 10-K · filed 2018-03-01 | |
| 2016-09-30 | $332.00K 10-Q · filed 2017-01-20 | |
| 2016-06-30 | $320.00K 10-Q/A · filed 2017-01-23 | |
| 2016-03-31 | $311.00K 10-Q/A · filed 2017-01-20 | |
| 2015-12-31 | $318.00K 10-K · filed 2017-03-16 | $391.00K 10-K · filed 2016-03-09 |
| 2015-09-30 | $322.00K 10-Q/A · filed 2017-01-20 | $415.00K 10-Q · filed 2015-11-09 |
| 2015-06-30 | $321.00K 10-Q/A · filed 2017-01-23 | $435.00K 10-Q · filed 2015-08-07 |
| 2015-03-31 | $321.00K 10-Q/A · filed 2017-01-20 | $497.00K 10-Q · filed 2015-05-06 |
| 2014-12-31 | $360.00K 10-Q/A · filed 2017-01-20 | $918.00K 10-K · filed 2015-03-12 |
| 2014-09-30 | $360.00K 10-Q/A · filed 2017-01-20 | |
| 2014-06-30 | $361.00K 10-Q · filed 2014-08-12 | |
| 2014-03-31 | $360.00K 10-Q · filed 2014-05-13 | |
| 2013-12-31 | $1.37M 10-K · filed 2015-03-12 | $361.00K 10-K · filed 2014-03-21 |
| 2013-09-30 | $360.00K 10-Q · filed 2013-11-13 | |
| 2013-06-30 | $360.00K 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $363.00K 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $334.00K 10-K · filed 2014-03-21 | $55.00K 10-K · filed 2013-03-15 |
| 2012-09-30 | $55.00K 10-Q · filed 2012-11-02 | |
| 2012-06-30 | $55.00K 10-Q · filed 2012-08-13 | |
| 2012-03-31 | $61.00K 10-Q · filed 2012-06-08 | |
| 2011-12-31 | $55.00K 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |